Pay in 4 interest-free payments of $6.52 Learn more
Ships within 48 hours · Estimated delivery Nov 11 - Nov 16
Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass
Licensed pharmacological options such as orlistat and semaglutide (Wegovy, per NICE TA875) may be appropriate for eligible individuals
A digital COA is available on request
The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue
While side effects are rare, some individuals may experience mild discomfort at the injection site or temporary symptoms such as dizziness or nausea
US$ 20.04
US$ 20.30
US$ 27.01
